拉斯类多增强了Thrombopoietin模拟的治疗活性
Xiansheng Zhao1, Yutuo Zheng2, Guosheng Gao3
1Department of Liver Disease, Ningbo No.2 Hospital, Ningbo, China.
研究人员开发了新型的融合蛋白,将血栓蛋白仿真 (TMP) 与弹性类多 (ELP) 结合起来,以改善血栓细胞衰减的治疗. 与现有治疗方法相比,这些ELP-TMP融合蛋白显示出延长半衰期和增强的血小板刺激活性.
科学领域:
- 生物技术是生物技术.
- 药理学 药理学 是一个学科.
- 蛋白质工程是指蛋白质工程.
背景情况:
- 血栓形成素 (TPO) 对于治疗血栓缩至关重要,但其临床应用受到免疫性和短半衰期的阻碍.
- TPO仿真 (TMP) 提供了一个替代方案,但需要与载体分子融合以优化药理动力学.
研究的目的:
- 设计ELP-TMP融合蛋白 (ELP120-2TMP和2TMP-ELP120) 以克服TPO和TMP的局限性.
- 评估这些新型融合蛋白的药理动力学特性,半衰期延长和血小板刺激功效.
主要方法:
- 开发了两个不同的ELP-TMP融合蛋白结构:ELP120-2TMP和2TMP-ELP120.
- 在体外表征EC50值以评估生物活性.
- 在小鼠体内研究以确定血小板刺激的峰值血小板反应,半衰期和曲线下面积 (AUC).
主要成果:
- 与单独的TMP (1小时) 相比,两种ELP-TMP融合蛋白均表现出明显更长的半衰期 (22.9小时和25.4小时).
- ELP120-2TMP和2TMP-ELP120表现出强烈的血小板刺激活性,EC50值分别为5.81 nM和10.88 nM.
- 在体内研究表明,复合人体TPO (rhTPO) 的融合蛋白对血小板刺激优于复合人体TPO (rhTPO),根据AUC分析 (p < 0.01).
结论:
- ELP-TMP融合蛋白代表了开发改善血小板缺血的治疗方法的有希望的战略.
- 与弹性类多的融合有效地延长了半衰期,并增强了TPO模仿的活性.
更多相关视频
07:03Imaging Denatured Collagen Strands In vivo and Ex vivo via Photo-triggered Hybridization of Caged Collagen Mimetic Peptides
Published on: January 31, 2014
10:12Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
相关概念视频
Peptide Bonds
Elastin is Responsible for Tissue Elasticity
Ligaments and tendons are made of dense regular connective tissue, but in ligaments not all fibers are parallel. Dense regular elastic tissue contains elastin fibers and...
Therapeutic Index
Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
Self-Evaluation: Self-Enhancement and Self-Verification
Bioavailability Enhancement: Drug Solubility Enhancement
